The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
De novo mutations in schizophrenia implicate synaptic networks
Open accessAbstract
Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While most children with SCN2A variants fit into one of these three categories, there are some exceptions, including epileptic encephalopathy with choreoathetoid movements [26,27], benign infantile seizures with late-onset episodic ataxia [28–31], childhood-onset epileptic encephalopathy [32], and schizophrenia [33,34].”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [33]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The human NDR2 gene (STK38l) has been identified as a susceptibility gene for neurodevelopmental disorders, intellectual disability (Madencioglu et al. 2021; Firth et al. 2009), and autism spectrum disorder (Fromer et al. 2014).”
From The Serine/Threonine Kinase NDR2 Regulates Integrin Signaling, Synapse Formation, and Synaptic Plasticity in the Hippocampus (2025) · cites this paper as Fromer et al. 2014
Experimental — accuracy not yet measuredIn the citing paper
“We tested for and found that genes in which rare variants increase risk of ASD and DD32,33 are also enriched for schizophrenia common variant associations.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“We controlled for a set of 10,360 genes with detectable expression in brain tissue measured as Fragments Per Kilobase of transcript per Million mapped reads (FPKM)32 to detect synaptic signals above signals simply reflecting the property of brain expression.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [80]
In the citing paper
“Protein-truncating variants (PTVs) are among the most interpretable associations as they suggest that the effect on disease most commonly tracks with decreasing expression of the gene18.”
From Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) · cites this paper as [18]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)9,12,27.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“we identified an ultra-rare splice donor variant in TAF1312, an ultra-rare nonsense variant in SETD1A16,17, and a single ultra-rare nonsense variant in NRXN1, a gene in which exonic deletions associate with schizophrenia18.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“Estimated 3rd and 5th principal components corresponded to previously observed Finnish and Northern-Southern Sweden clines12 (Supplementary Fig. 12d)”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Rate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Self-citationDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,004
Chang, X., Lima, L. D. A., Liu, Y., Li, J., Li, Q. S., Abou‐Sleiman, P. M., & Hakonarson, H. H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00434 · Cited by 36
Wang, Q., Wu, H. M., Yue, W., Yan, H., Zhang, Y., Tan, L., Deng, W., Chen, Q., Yang, G., Lu, T., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3039 · Cited by 36
Openshaw, R. L., Kwon, J., McColl, A., Penninger, J. M., Cavanagh, J., Pratt, J. A., & MORRIS, B. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1408-5 · Cited by 36
Whole-exome sequencing of 81 individuals from 27 multiply affected bipolar disorder families
Forstner, A. J., Fischer, S. B., Schenk, L. M., Strohmaier, J., Maaser‐Hecker, A., Reinbold, C. S., Sivalingam, S., Hecker, J., Streit, F., Degenhardt, F., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0732-y · Cited by 36
Ayuso‐Dolado, S., Esteban-Ortega, G. M., Vidaurre, Ó. G., & Díaz‐Guerra, M. (2021) · Theranostics · doi:10.7150/thno.60701 · Cited by 36
Breen, M. S., Wingo, A. P., Koen, N., Donald, K. A., Nicol, M., Zar, H. J., Ressler, K. J., Buxbaum, J. D., & Stein, D. J. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.016 · Cited by 35
Flint, J., & Ideker, T. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008519 · Cited by 36
The Adenosine Neuromodulation System in Schizophrenia
Rial, D., Lara, D. R., & Cunha, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00016-7 · Cited by 35
Schizophrenia Genetics Comes of Age
Need, A. C., & Goldstein, D. B. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.015 · Cited by 35
Coughlin, J. M., Tanaka, T., Marsman, A., Wang, H., Bonekamp, S., Kim, P. K., Higgs, C., Varvaris, M., Edden, R. A. E., Pomper, M. G., et al. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303104811 · Cited by 35
Endo, R., Takashima, N., Nekooki-Machida, Y., Komi, Y., Hui, K. K., Takao, M., Akatsu, H., Murayama, S., Sawa, A., & Tanaka, M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.03.008 · Cited by 35
Penrod, R. D., Kumar, J., Smith, L. N., McCalley, D. M., Nentwig, T. B., Hughes, B. W., Barry, G. M., Glover, K., Taniguchi, M., & Cowan, C. W. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12561 · Cited by 35
Spatial organization of palmitoyl acyl transferases governs substrate localization and function
Philippe, J. M., & Jenkins, P. M. (2019) · Molecular Membrane Biology · doi:10.1080/09687688.2019.1710274 · Cited by 35
Crosstalk among Calcium ATPases: PMCA, SERCA and SPCA in Mental Diseases
Boczek, T., Sobolczyk, M., Mackiewicz, J., Lisek, M., Ferenc, B., Guo, F., & Żylińska, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062785 · Cited by 35
Rac-maninoff and Rho-vel: The symphony of Rho-GTPase signaling at excitatory synapses
Duman, J. G., Blanco, F. A., Cronkite, C. A., Ru, Q., Erikson, K., Mulherkar, S. A., Saifullah, A. B., Firozi, K., & Tolias, K. F. (2021) · Small GTPases · doi:10.1080/21541248.2021.1885264 · Cited by 35
Rosenbrock, H., Dorner‐Ciossek, C., Giovannini, R., Schmid, B., & Schuelert, N. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.001071 · Cited by 35
EvoTol: a protein-sequence based evolutionary intolerance framework for disease-gene prioritization
Rackham, O. J. L., Shihab, H. A., Johnson, M. R., & Petretto, E. G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1322 · Cited by 35
Dunayevich, E., Buchanan, R. W., Chen, C., Yang, J., Nilsen, J., Dietrich, J., Sun, H. Q., & Marder, S. R. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.027 · Cited by 35
Hauser, M. J., Isbrandt, D., & Roeper, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.013 · Cited by 35
De novo mutations of TUBA3D are associated with keratoconus
Hao, X., Chen, P., Zhang, Y., Li, S., Shi, W., & Gao, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13162-0 · Cited by 35
Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis
Jézéquel, J., Johansson, E. M., Leboyer, M., & Groc, L. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.05.002 · Cited by 35
Torrico, B., Shaw, A. D., Mosca, R., Vivó-Luque, N., Hervás, A., Fernàndez-Castillo, N., Aloy, P., Bayés, M., Fullerton, J. M., Cormand, B., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180184 · Cited by 34
Larimore, J. L., Zlatic, S. A., Gokhale, A., Tornieri, K., Singleton, K. S., Mullin, A. P., Tang, J. X., Talbot, K., & Faúndez, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553750 · Cited by 34
Nebel, R. A., Zhao, D., Pedrosa, E., Kirschen, J., Lachman, H. M., Zheng, D., & Abrahams, B. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148039 · Cited by 34
What Next in Schizophrenia Genetics for the Psychiatric Genomics Consortium?
Corvin, A. P., & Sullivan, P. F. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw014 · Cited by 34
Challenges and opportunities for the development of new antipsychotic drugs
Forray, C., & Buller, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.009 · Cited by 34
Evgrafov, O. V., Armoskus, C., Wrobel, B., Spitsyna, V. N., Souaiaia, T., Herstein, J. S., Walker, C., Nguyen, J. D. K., Camarena, A., Weitz, J., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.005 · Cited by 34
A Systematic Review of the Potential Use of Neurofeedback in Patients With Schizophrenia
Gandara, V., Pineda, J. A., Shu, I.-W., & Singh, F. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa005 · Cited by 34
Canalization and Robustness in Human Genetics and Disease
Gibson, G. C., & Lacek, K. A. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-022020-022327 · Cited by 34
Kim, S.-G., Lee, S., Kim, Y., Park, J., Woo, D., Kim, D., Li, Y., Shin, W., Kang, H., Yook, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22908-4 · Cited by 34
Targeting synaptic plasticity in schizophrenia: insights from genomic studies
Mould, A. W., Hall, N., Milošević, I., & Tunbridge, E. M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.014 · Cited by 34
Sanders, B., D’Andrea, D., Collins, M. O., Rees, E., Steward, T. G. J., Zhu, Y., Chapman, G., Legge, S. E., Pardiñas, A. F., Harwood, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27601-0 · Cited by 34
Self-citationLu, C., Chen, Q., Zhou, T. G., Bozic, D., Fu, Z., Pan, J. Q., & Feng, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.173 · Cited by 34
Chiocchetti, A. G., Haslinger, D., Stein, J. L., de la Torre-Ubieta, L., Cocchi, E., Rothämel, T., Lindlar, S., Waltes, R., Fulda, S., Geschwind, D. H., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.119 · Cited by 34
Forsyth, J. K., Bachman, P., Mathalon, D. H., Roach, B. J., Ye, E. M., & Asarnow, R. F. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw193 · Cited by 34
Liu, Y., Liang, Y., Çiçek, A. E., Li, Z., Li, J., Muhle, R., Krenzer, M., Mei, Y., Wang, Y., Knoblauch, N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.023 · Cited by 34
Identification of RELN variation p.Thr3192Ser in a Chinese family with schizophrenia
Zhou, Z., Hu, Z., Zhang, L., Hu, Z., Liu, H., Liu, Z., Du, J., Zhao, J., Zhou, L., Xia, K., et al. (2016) · Scientific Reports · doi:10.1038/srep24327 · Cited by 33
The effect of ketamine on the consolidation and extinction of contextual fear memory
Clifton, N. E., Thomas, K. L., & Hall, J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117748903 · Cited by 33
JARID2 haploinsufficiency is associated with a clinically distinct neurodevelopmental syndrome
Verberne, E. A., Goh, S., England, J., van Ginkel, M., Rafael‐Croes, L., Maas, S. M., Polstra, A. M., Zárate, Y. A., Bosanko, K. A., Pechter, K. B., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-00992-z · Cited by 33
The Genetics of Neuropsychiatric Diseases: Looking In and Beyond the Exome
Heinzen, E. L., Neale, B. M., Traynelis, S. F., Allen, A. S., & Goldstein, D. B. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-034136 · Cited by 33
Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms
Abela, L., & Kurian, M. A. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0205-0 · Cited by 33
Protein palmitoylation: biological functions, disease, and therapeutic targets
Qian, Y., Zhao, Y., & Zhang, F. (2025) · MedComm · doi:10.1002/mco2.70096 · Cited by 32
Beta-catenin in schizophrenia: Possibly deleterious novel mutation
Levchenko, А., Davtian, S. E., Freylichman, O., Zagrivnaya, M., Kostareva, A. A., & Malashichev, Y. B. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.014 · Cited by 32
Synapse pathology and translational applications for schizophrenia
Hayashi‐Takagi, A. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.09.001 · Cited by 32
Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development
Chen, X., Ku, L., Mei, R., Liu, G., Xu, C., Wen, Z., Zhao, X., Wang, F., Xiao, L., & Feng, Y. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0028-z · Cited by 32
Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia
Dobrindt, K., Zhang, H., Das, D., Abdollahi, S., Prorok, T., Ghosh, S. D., Weintraub, S. J., Genovese, G., Powell, S. K., Lund, A. N., et al. (2020) · Complex Psychiatry · doi:10.1159/000512716 · Cited by 32
Self-citationMercaldo, V., Vidimova, B., Gastaldo, D., Fernández, E., Lo, A. C., Cencelli, G., Pedini, G., Rubeis, S. D., Longo, F., Klann, E., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.008 · Cited by 32
Self-citationnArgBP2 regulates excitatory synapse formation by controlling dendritic spine morphology
Lee, S., Kim, Y., Han, J.-K., Park, H.-Y., Lee, U., Na, M., Jeong, S., Chung, C., Cestra, G., & Chang, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600944113 · Cited by 32
Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies
Lin, Z., Liu, Z., Li, X., Feng, L., Hu, Y., Chen, B., Wang, Z., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00208-6 · Cited by 32
Marziali, F., Dizanzo, M. P., Cavatorta, A. L., & Gardiol, D. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0350 · Cited by 32
Kast, D. J. E., & Domínguez, R. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-09-0600 · Cited by 32
Nielsen, L. D., Pedersen, C. P., Erlendsson, S., & Teilum, K. (2019) · Structure · doi:10.1016/j.str.2019.04.001 · Cited by 32
‘Arc’-hitecture of normal cognitive aging
Myrum, C., Moreno‐Castilla, P., & Rapp, P. R. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101678 · Cited by 31
Alfieri, A., Sorokina, O., Adrait, A., Angelini, C., Russo, I., Morellato, A., Matteoli, M., Menna, E., Erba, E. B., Mclean, C., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00212 · Cited by 31
Mini‐review: Update on the genetics of schizophrenia
Coelewij, L., & Curtis, D. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12259 · Cited by 31
γ2 GABAAR Trafficking and the Consequences of Human Genetic Variation
Lorenz‐Guertin, J. M., Bambino, M. J., & Jacob, T. C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00265 · Cited by 31
Griesius, S., O’Donnell, C., Waldron, S., Thomas, K. L., Dwyer, D. M., Wilkinson, L. S., Hall, J., Robinson, E. S. J., & Mellor, J. R. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01277-6 · Cited by 31
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
Lago, S. G., & Bahn, S. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00290-4 · Cited by 31
Chang, X., Zhao, W. D., Kang, J., Xiang, S., Xie, C., Hernández, H. C., Palaniyappan, L. K., & Feng, J. (2022) · Schizophrenia · doi:10.1038/s41537-022-00308-x · Cited by 31
O’Tuathaigh, C. M. P., & Waddington, J. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.016 · Cited by 31
Single-cell trajectory analysis of human homogenous neurons carrying a rare RELN variant
Arioka, Y., Shishido, E., Kubo, H., Kushima, I., Yoshimi, A., Kimura, H., Ishizuka, K., Aleksić, B., Maeda, T., Ishikawa, M., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0177-8 · Cited by 31
McRae, J. F., Clayton, S., Fitzgerald, T. W., Kaplanis, J., Prigmore, E., Rajan, D., Sifrim, A., Aitken, S., Akawi, N., Alvi, M., et al. (2016) · doi:10.1101/049056 · Cited by 30
Genome-wide association analysis identifies common variants influencing infant brain volumes
Xia, K., Zhang, J., Ahn, M., Jha, S., Crowley, J. J., Szatkiewicz, J., Li, T., Zou, F., Zhu, H., Hibar, D., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.159 · Cited by 30
Vrieze, S. I., Malone, S. M., Vaidyanathan, U., Kwong, A. M., Kang, H. M., Zhan, X., Flickinger, M., Irons, D. E., Jun, G., Locke, A. E., et al. (2014) · Psychophysiology · doi:10.1111/psyp.12350 · Cited by 30
Overview of genetic research in anorexia nervosa: The past, the present and the future
Brandys, M. K., de Kovel, C. G. F., Kas, M. J., Elburg, A. A. V., & Adan, R. A. H. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22400 · Cited by 30
High-throughput sequencing of the synaptome in major depressive disorder
Pirooznia, M., Wang, T., Avramopoulos, D., Potash, J. B., Zandi, P. P., & Goes, F. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.98 · Cited by 30
Genetics of Childhood-onset Schizophrenia 2019 Update
Forsyth, J. K., & Asarnow, R. F. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.007 · Cited by 30
Li, M., Shen, L., Chen, L., Huai, C., Huang, H., Wu, X., Yang, C., Ma, J., Zhou, W., Du, H., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0708-y · Cited by 30
The crosstalk between 5-HT2AR and mGluR2 in schizophrenia
Saha, S., & González‐Maeso, J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109489 · Cited by 30
Distorted neurocomputation by a small number of extra-large spines in psychiatric disorders
Obi-Nagata, K., Suzuki, N., Miyake, R., MacDonald, M. L., Fish, K. N., Ozawa, K., Nagahama, K., Okimura, T., Tanaka, S., Kano, M., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade5973 · Cited by 30
Incorporating Functional Information in Tests of Excess De Novo Mutational Load
Jiang, Y., Han, Y., Petrovski, S., Owzar, K., Goldstein, D. B., & Allen, A. S. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.013 · Cited by 30
Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk
Kranz, T. M., Goetz, R. R., Walsh‐Messinger, J., Goetz, D. M., Antonius, D., Dolgalev, I., Heguy, A., Seandel, M., Malaspina, D., & Chao, M. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.07.002 · Cited by 30
Pfaffenseller, B., Magalhães, P. V. D. S., Bastiani, M. A. D., Castro, M. A. A., Gallitano, A. L., Kapczinski, F. P., & Klamt, F. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.78 · Cited by 30
Etemadikhah, M., Niazi, A., Wetterberg, L., & Feuk, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-57467-z · Cited by 30
Loebrich, S. (2014) · Communicative & Integrative Biology · doi:10.4161/cib.28740 · Cited by 30
Somatic mutations in disorders with disrupted brain connectivity
Lee, J. H. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.53 · Cited by 29
Kendler, K. S., Ohlsson, H., Keefe, R. S. E., Sundquist, K., & Sundquist, J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.78 · Cited by 29
The Candidate Schizophrenia Risk Gene DGCR2 Regulates Early Steps of Corticogenesis
Molinard‐Chenu, A., & Dayer, A. G. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.015 · Cited by 29
Temporal proteomic profiling of postnatal human cortical development
Breen, M. S., Özcan, S., Ramsey, J. M., Wang, Z., Ma’ayan, A., Rustogi, N., Gottschalk, M. G., Webster, M. J., Weickert, C. S., Buxbaum, J. D., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0306-4 · Cited by 29
Guo, Z., Chen, W.-C., Huang, J., Wang, L., & Qian, L. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0609-1 · Cited by 29
Upton, D. H., Popovic, K., Fulton, R., & Kassiou, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-66122-6 · Cited by 29
Genetic association of FMRP targets with psychiatric disorders
Clifton, N. E., Rees, E., Holmans, P., Pardiñas, A. F., Harwood, J. C., Florio, A. D., Kirov, G., Walters, J., O’Donovan, M. C., Owen, M. J., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00912-2 · Cited by 29
Self-citationMarchi, M., Galli, G., Magarini, F. M., Mattei, G., & Galeazzi, G. M. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1885648 · Cited by 29
Carlström, E. L., Niazi, A., Etemadikhah, M., Halvardson, J., Enroth, S., Stockmeier, C. A., Rajkowska, G., Nilsson, B., & Feuk, L. (2021) · Genes · doi:10.3390/genes12081242 · Cited by 29
Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis
Espana, A., Seth, H., Jézéquel, J., Huang, T., Bouchet, D., Lepleux, M., Gréa, H., Bechter, K., Schneider, M., Hanse, E., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01549-7 · Cited by 29
Characterization of six CaMKIIα variants found in patients with schizophrenia
Brown, C. N., Cook, S. G., Allen, H. F., Crosby, K. C., Singh, T., Coultrap, S. J., & Bayer, K. U. (2021) · iScience · doi:10.1016/j.isci.2021.103184 · Cited by 29
Spatiotemporal and genetic regulation of A-to-I editing throughout human brain development
Dredge, W. H., Fan, X., Sloofman, L. G., Liang, L., Mossotto, E., Moore, K., Zipkowitz, S., Wang, M., Zhang, B., Wang, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111585 · Cited by 29
Parnell, E., Culotta, L., Forrest, M. P., Jalloul, H. A., Eckman, B. L., Loizzo, D. D., Horan, K. E., Santos, M. D., Piguel, N. H., Tai, D. J. C., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.005 · Cited by 29
Folsom, T. D., THURAS, P. D., & Fatemi, S. H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.012 · Cited by 29
Novel treatment strategies for schizophrenia from improved understanding of genetic risk
Morris, B., & Pratt, J. A. (2014) · Clinical Genetics · doi:10.1111/cge.12485 · Cited by 29
Kassan, A., Egawa, J., Zhang, Z., Almenar‐Queralt, A., Nguyen, Q. M., Lajevardi, Y., Kim, K., Posadas, E., Jeste, D. V., Roth, D. M., et al. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00481.2016 · Cited by 29
Gokhale, A., Hartwig, C. L., Freeman, A. A. H., Das, R., Zlatic, S. A., Vistein, R., Burch, A. M., Carrot, G., Lewis, A. F., Nelms, S., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1321-16.2016 · Cited by 29
McKinney, B. C., Ding, Y., Lewis, D. A., & Sweet, R. A. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.297 · Cited by 29
Neurogenetic analysis of childhood disintegrative disorder
Gupta, A. R., Westphal, A., Yang, D. Y. ‐., Sullivan, C. A. W., Eilbott, J. A., Zaidi, S., Voos, A. C., Wyk, B. C. V., Ventola, P., Waqar, Z., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0133-0 · Cited by 29
Arc ubiquitination in synaptic plasticity
Mabb, A. M., & Ehlers, M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.009 · Cited by 29
Hartwig, C. L., Monis, W. J., Chen, X., Dickman, D. K., Pazour, G. J., & Faúndez, V. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22542 · Cited by 29
lncRNA Neat1 regulates neuronal dysfunction post-sepsis via stabilization of hemoglobin subunit beta
Wu, Y., Li, P., Liu, L., Goodwin, A. J., Halushka, P. V., Hirose, T., Nakagawa, S., Zhou, J., Liu, M., & Fan, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.011 · Cited by 28
FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability
Clifton, N. E., Thomas, K. L., Wilkinson, L. S., Hall, J., & Trent, S. (2020) · Complex Psychiatry · doi:10.1159/000506858 · Cited by 28
Eeltink, E., van der Horst, M. Z., Zinkstok, J., Aalfs, C. M., & Luykx, J. J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.021 · Cited by 28
Expression and function of circular RNAs in the mammalian brain
Xu, K., Zhang, Y., & Li, J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03780-3 · Cited by 29
Metadata
- Authors
- Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., Carrera, N., Humphreys, I., Johnson, J. S., Roussos, P., Barker, D. D., Banks, E., Milanova, V., Grant, S. G., Hannon, E., Rose, S. A., Chambert, K., Mahajan, M., Scolnick, E. M., Moran, J. L., Kirov, G., Palotie, A., McCarroll, S. A., Holmans, P., Sklar, P., Owen, M. J., Purcell, S. M., & O’Donovan, M. C.
- Affiliations
- Broad Institute (US)
- Cardiff University (GB)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- Medical University of Sofia (BG)
- University of Edinburgh (GB)
- Corresponding author
- Owen, Michael J.
- ORCID
- Fromer, Menachem
- Pocklington, Andrew J.
- Williams, Hywel J.
- Dwyer, Sarah
- Gormley, Padhraig
- Rees, Elliott
- Palta, Priit
- Ruderfer, Douglas M.
- Carrera, Noa
- Johnson, Jessica S.
- Roussos, Panos
- Banks, Eric
- Milanova, Vihra
- Grant, Seth G.
- Hannon, Eilis
- Rose, Samuel A.
- Scolnick, Edward M.
- Moran, Jennifer L.
- Kirov, George
- Palotie, Aarno
- McCarroll, Steven A.
- Holmans, Peter
- Sklar, Pamela
- Owen, Michael J.
- Purcell, Shaun M.
- O’Donovan, Michael C.
- Venue
- Nature
- Published
- 2014-01-22
- Volume
- 506
- Issue
- 7487
- Pages
- 179-184
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4237002
- OpenAlex
- W2023962370
- Cited by
- 1,617
- References
- 43
- Citations by year
- 2026: 39 · 2025: 68 · 2024: 64 · 2023: 91 · 2022: 114 · 2021: 134 · 2020: 127 · 2019: 168 · 2018: 149 · 2017: 193 · 2016: 186 · 2015: 164 · 2014: 120
- FWCI
- 168.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- Wellcome Trust (089062, WT 098051, WT089062, 098051)
- Medical Research Council (MR/L010305/1)
- National Institute of Mental Health (P50MH066392, R01MH071681, R01MH099126)
- National Human Genome Research Institute (R01HG005827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- schizophrenia, de novo mutations, synaptic proteins, glutamatergic synapses, activity-regulated cytoskeleton-associated protein, NMDA receptor, FMRP, actin filament dynamics, autism spectrum disorder, intellectual disability, neurodevelopmental disorders, synaptic efficacy
- MeSH terms
- Child Development Disorders, Pervasive, Cytoskeletal Proteins, Humans, Intellectual Disability, Models, Neurological, Mutation, Nerve Net, Nerve Tissue Proteins, Neural Pathways, Phenotype, RNA, Messenger, Schizophrenia, Substrate Specificity, Synapses, Receptors, N-Methyl-D-Aspartate, Fragile X Messenger Ribonucleoprotein 1, Exome, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
